Bladder Cancer

FDA Approves New Immunotherapy Drug for Bladder Cancer

The FDA approved immunotherapy drug Tecentriq (atezolizumab), a checkpoint inhibitor that targets the PD-1/PD-L1 pathway, for bladder cancer.

Adding Chemo Improves Outcomes from Bladder Cancer Radiation

British researchers have found that combining radiation with 2 chemotherapy drugs helped bladder cancer patients live longer than those who had radiation alone.

World Health Organization Says Diesel Exhaust Causes Cancer

A group of experts from the World Health Organization (WHO) has classified diesel engine exhaust as a carcinogen – a substance that causes cancer.